SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-008942
Filing Date
2024-03-06
Accepted
2024-03-06 08:00:38
Documents
16
Period of Report
2024-03-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44855
2 ex99-1.htm EX-99.1 25315
3 ex99-2.htm EX-99.2 14573
  Complete submission text file 0001493152-24-008942.txt   272364

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE maia-20240305.xsd EX-101.SCH 3024
5 XBRL LABEL FILE maia-20240305_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE maia-20240305_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3712
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24724404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)